Yasmin was first approved by The Food & Drug Administration (FDA) in 2001 for women to use as birth control.
In 2008, the FDA issued Bayer Corp. a warning letter regarding false claims made in two Yaz television commercials. These false claims involved the ability of Yaz to treat premenstrual syndrome (PMS) and all types of acne. As a result, the company stopped running the ads, and later embarked on an advertising campaign that corrected the deceptive claims made in those commercials.
Yasmin has been associated with:
– Pulmonary Embolism (PE)
– Deep Vein Thrombosis (DVT)
– Heart Attack
– Stroke
– Death
A study published earlier in August in the British Medical Journal suggests that the risk of suffering a Yaz or Yasmin blood clot may be greater than with some other types of birth control pills and 6.3 times greater than taking no form of oral contraceptive.
Yaz and Yasmin are currently among the most popular types of birth control sold in the United States, with Yaz accounting for 17.7% of the birth control market last year and Yasmin accounting for another 11%.
The lawyers at Dr. Shezad Malik Law Firm represent women throughout the United States who are pursuing a Yaz lawsuit or Yasmin lawsuit after suffering a blood clot injury, such as deep vein thrombosis, pulmonary embolism, heart attack, stroke or death, as well as gallbladder disease.
Yasmin and Yaz lawsuits filed allege that Bayer failed to adequately warn about the increased risk of serious heart and health problems associated with their birth control when compared to other available pills. They not only minimized the blood clot risk with Yaz and Yasmin, but also heavily marketing the drugs through deceptive advertisements designed to encourage doctors and patients to use their birth control pill over other available forms that may not present as great of a risk.
While blood clots are a risk associated with all forms of birth control, this new birth control pill study provides further evidence that the Yaz and Yasmin blood clot problems are not the same as all other types of available birth control pills.
Researchers looked at 1,524 women between 18 and 50 who were diagnosed with a first deep vein thrombosis (DVT) of the leg, which is a blood clot that forms in the deep veins, or pulmonary embolism, which is a blood clot that travels through the blood stream and gets lodged in the lung, and compared them with 1,760 health women. The data indicates that women taking oral birth control pills had a fivefold increase in the risk of blood clots, but some hormones carry more risk than others.
When compared to women who were using no oral contraceptives, researchers found that users who took drospirenone, the progestin contained in both Yaz and Yasmin, had a 6.3 times greater risk of blood clots. By comparison, women who used birth control pills containing levonorgestrel had the lowest risk, with only a nearly 4 times increase over women taking no birth control.
The Yas and Yasmin lawyers at Dr. Shezad Malik Law Firm are reviewing and investigating potential claims throughout the United States. As a result of the drug makers’ failure to adequately research the safety of these birth control pills and inadequate warnings provided to consumers and the medical community, many otherwise healthy women have suffered serious and life-threatening injuries.
If you or a family member has been personally injured because of the fault of someone else: by the use of dangerous drugs, bad products, or toxic injury etc then please contact the Fort Worth Texas Defective Drugs Product Liability Attorney Dr. Shezad Malik. For a no obligation, free case analysis, please call 817-255-4001 or Contact Me Online.
The Dr. Shezad Malik Law is currently evaluating and accepting Yaz, Yasmin and Ocella Side Effect cases.